CRM Cancer Research Results
CRM, Calorie restriction mimetics (CRMs): Click to Expand ⟱
| Source: |
| Type: |
Calorie restriction mimetics (CRMs) are compounds that appear to mimic some of the biochemical effects of caloric restriction without the need to actually reduce caloric intake.
-Resveratrol:Known for activating sirtuins (e.g., SIRT1)
-Curcumin
-Quercetin
-EGCG
-Spermidine
-Fisetin
-Berberine
-Pterostilbene
-Hydroxytyrosol
-Sulforaphane
-Cinnamaldehyde
-Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN)
-Alpha-Ketoglutarate (AKG)
-Rapamycin (Sirolimus
|
Scientific Papers found: Click to Expand⟱
*CRM↑, *HATs↓, *NF-kB↓, *EP300↓,
*antiOx↑, *ROS∅, *CRM↑,
*CRM↑, *neuroP↑, *AChE↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↑, *ROS↓, *SOD↑, *Catalase↑, *GSH↑, *GSTs↑, *MDA↓, *lipid-P↓, *NRF2↑, *HO-1↑, *iNOS↓, *NO↓, *TAC↑, *NOX4↓, *Inflam↓, *IL1↓, *IL6↓, *IL8↓, *IL1β↓, *TNF-α↓, *TLR2↓, *TLR4↓, *VCAM-1↓, *ICAM-1↓, *STAT3↓, *NF-kB↓, *ERK↓, *BP↓, ROS↓, PGE2↓, cardioP↑, *neuroP↑, *creat↓, *RenoP↑, *CRM↑,
*AntiDiabetic↑, *AntiAge↑, *toxicity⇅, *CRM↑, *Strength↑, *LDL↓, *AMPK↑, *TAC↑, *ROS↓, *Inflam↓, Risk↓, *cardioP↑, *ALAT↓, *NRF2↑, *SOD2↑, *TrxR1↑, *NQO1↑, *NQO2↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27/CDKN1B↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,
*CRM↑, *OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*antiOx↓, *ROS↑, *SOD↑, *GSH↑, *NRF2↑, *MDA↓, *HNE↓, *Inflam↓, *MAPK↓, *IL6↓, *TNF-α↓, *HO-1↑, *cardioP↑, *neuroP↑, *CRM↑, *NLRP3↓,
*AntiAge↑, *IGF-1↓, *AMPK↑, *CRM↑, *PGC-1α↑, *mtDam↓, *motorD↑, *hepatoP↑, *Dose↝,
*AMPK↑, *SIRT1↑, *PGC-1α↑, *BP↓, *CRM↑, *Dose↝, *mtDam↓, *ALAT↓, *hepatoP↑,
*EP300↓, *mTORC1↓, *CRM↑, *HATs↓, *p62↓, *AntiAge↑, AntiCan↑,
Showing Research Papers: 1 to 11 of 11
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 11
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1, ROS↑, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, Casp↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
mTOR↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, p27/CDKN1B↓, 1, pRB↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCP↓, 1,
Barriers & Transport(tgid=15) ⓘ
MMP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
PGE2↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, cardioP↑, 1, Risk↓, 2,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↓, 1, antiOx↑, 2, Catalase↑, 1, GSH↑, 2, GSTs↑, 1, HNE↓, 1, HO-1↑, 2, lipid-P↓, 1, MDA↓, 2, NOX4↓, 1, NQO1↑, 1, NRF2↑, 3, ROS↓, 3, ROS↑, 1, ROS∅, 1, SOD↑, 2, SOD2↑, 1, TAC↑, 2, TrxR1↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
Insulin↓, 1, mtDam↓, 2, PGC-1α↑, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 2, AMPK↑, 4, CRM↑, 11, glucose↓, 1, glyC↓, 1, LDL↓, 1, SIRT1↑, 1,
Cell Death(tgid=5) ⓘ
iNOS↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
ERK↓, 1, MAPK↓, 1, STAT3↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
HATs↓, 2,
Protein Folding & ER Stress(tgid=8) ⓘ
NQO2↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
p62↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
EP300↓, 2, IGF-1↓, 1, mTORC1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
NO↓, 1, VCAM-1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
ICAM-1↓, 1, IL1↓, 1, IL1β↓, 1, IL6↓, 2, IL8↓, 1, Inflam↓, 3, NF-kB↓, 2, NLRP3↓, 1, TLR2↓, 1, TLR4↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1,
Protein Aggregation(tgid=19) ⓘ
AGEs↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, Dose↝, 2, Half-Life↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 2, BP↓, 2, creat↓, 1, IL6↓, 2,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 3, AntiDiabetic↑, 2, cardioP↑, 3, hepatoP↑, 3, motorD↑, 1, neuroP↑, 4, OS↑, 1, RenoP↑, 1, Strength↑, 1, toxicity⇅, 1, toxicity↝, 1,
Total Targets: 72
Scientific Paper Hit Count for: CRM, Calorie restriction mimetics (CRMs)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:1128 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page